Siren, L.L.C. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0002005245

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHealth TiltHigh Turnover how tags are computed

Q3 2026 Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024

Q3 2026 · 109 positions · Total reported value $4.21B · Top-10 concentration 47.5% · Updated 2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.7% · 15 new · 36 cut · 22 exited

Active Share (vs S&P 500): 97.6% · vs QQQ: 97.6% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -13.5% · vs SPY -15.6% · Prev Value $4.93B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -4.2% · vs SPY -6.4% · Latest Value $4.21B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2026 13F filing, Siren, L.L.C. disclosed 109 equity positions with a combined reported value of $4.21B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 47.5% of reported value. HoldingsHub classifies the profile as Mid / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2026 were SRRK ($453.00M), KYMR ($311.32M), ERAS ($193.48M). By sector, the heaviest allocations are Health Care 94.0%, Technology 4.2%. Versus the prior quarter, allocation shifted toward Health Care (+1.9pp) and away from Financials (-0.7pp), Other (-0.7pp).

Versus the prior quarter, Siren, L.L.C. opened 15 new positions, trimmed 36 and fully exited 22, a turnover rate of 55.7% of positions. The portfolio's overlap with the prior quarter was 72% of names.

The largest new positions opened in Q3 2026 were VNDA ($38.40M), ASND ($29.62M), DARE ($15.20M).

Of the 22 positions fully exited versus the prior quarter, the largest were DFTX ($66.77M), CRNX ($53.17M), COF ($34.43M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2026)

  • VNDA VANDA PHARMACEUTICALS INC · $38.40M
  • ASND ASCENDIS PHARMA A/S · $29.62M
  • DARE YARROW BIOSCIENCE INC · $15.20M
  • SKHY SK HYNIX INC · $14.73M
  • GHRS GH RESEARCH PLC · $14.09M
  • ACRS ACLARIS THERAPEUTICS INC · $10.65M
  • CBIO CRESCENT BIOPHARMA INC. · $5.84M
  • WSE WISE GROUP PLC · $4.02M

Fully Exited (vs previous quarter)

  • DFTX DEFINIUM THERAPEUTICS INC · prev qtr: $66.77M
  • CRNX CRINETICS PHARMACEUTICALS IN · prev qtr: $53.17M
  • COF CAPITAL ONE FINANCIAL CORP · prev qtr: $34.43M
  • SION SIONNA THERAPEUTICS INC · prev qtr: $26.86M
  • ORKA ORUKA THERAPEUTICS INC · prev qtr: $23.79M
  • MPLT MAPLIGHT THERAPEUTICS INC · prev qtr: $16.13M
  • PDD PDD HOLDINGS INC · prev qtr: $7.25M
  • AAPL APPLE INC · prev qtr: $6.66M

Insider Transactions (Form 4)

Latest Siren, L.L.C. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Siren, L.L.C. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 116 positions worth $4.93B in total. HoldingsHub carries 8 quarters of its filings (Q3 2024–Q2 2026).

Portfolio Structure

  • 116 positions · $4.93B reported value (Q2 2026)
  • Top 10 holdings = 44.8% of reported value
  • Largest position: SRRK (SCHOLAR ROCK HLDG CORP) at 10.7%
  • Average position size: $42.48M

Sector Tilt

  • Health Care 92.0%
  • Information Technology 4.5%
  • Consumer Discretionary 1.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 25 new, 32 added, 21 reduced, 9 exited
  • 38 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall direction and market view: The fund is actively reducing exposure to most top-10 holdings (7/10) while selectively adding to a few, suggesting a cautious stance on current biotech/healthcare positions but targeted bets on specific catalysts. 2. Key moves: - Added: ERAS (+15.8% shares), TNGX (+9.8%), ARWR (+33.5%) - Reduced: SRRK (-2.1%), KYMR (-5.1%), RVMD (-5.6%), MANE (-20.0%), EWTX (-11.9%), RYTM (-4.4%) - Hold: ONC (no change) 3. Portfolio structure: Highly active, concentrated in Health Care (100% top-10), with high risk appetite (small-cap biotech/therapeutics). 4. Per-holding one-liner: - SRRK: Scholar Rock (biopharma, unverified) - KYMR: Kymera Therapeutics (drug discovery, unverified) - ERAS: Erasca (cancer therapeutics, unverified) - RVMD: Revolution Medicines (cancer R&D, unverified) - ONC: BEONE MEDICINES (oncology, unverified) - TNGX: Tango Therapeutics (cancer genomics, unverified) - MANE: Veradermics (dermatology, unverified) - ARWR: Arrowhead Pharmaceuticals (gene therapy, unverified) - EWTX: Edgewise Therapeutics (muscle disorders, unverified) - RYTM: Rhythm Pharmaceuticals (obesity/rare disease, unverified) 5. Style summary: Cautiously selective biotech fund trimming broadly while doubling down on high-conviction catalysts.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice. · AI generated 2026-11-13 04:12

Sector Allocation

Health Care 94.0%
Technology 4.2%
Financials 0.2%
Energy 0.0%
Other 0.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 9.38M $453.00M 10.76%
10.76%
Reduce
2 2.78M $311.32M 7.39%
7.39%
Reduce
3 13.20M $193.48M 4.60%
4.60%
Add
4 850.00K $174.47M 4.14%
4.14%
Reduce
5 465.00K $170.16M 4.04%
4.04%
Hold
6 6.78M $169.26M 4.02%
4.02%
Add
7 1.32M $160.54M 3.81%
3.81%
Reduce
8 2.29M $149.91M 3.56%
3.56%
Add
9 2.80M $113.85M 2.70%
2.70%
Reduce
10 1.09M $103.43M 2.46%
2.46%
Reduce
11 5.50M $102.41M 2.43%
2.43%
Reduce
12 2.99M $96.62M 2.29%
2.29%
Hold
13 44.30M $83.29M 1.98%
1.98%
Hold
14 868.60K $77.33M 1.84%
1.84%
Reduce
15 3.40M $74.27M 1.76%
1.76%
Add
16 2.37M $72.97M 1.73%
1.73%
Add
17 2.48M $72.19M 1.72%
1.72%
Add
18 1.48M $67.62M 1.61%
1.61%
Reduce
19 1.70M $66.52M 1.58%
1.58%
Reduce
20 2.42M $62.52M 1.49%
1.49%
Hold
21 3.26M $58.90M 1.40%
1.40%
Reduce
22 888.40K $58.15M 1.38%
1.38%
Hold
23 7.69M $55.60M 1.32%
1.32%
Hold
24 2.00M $51.88M 1.23%
1.23%
Hold
25 1.61M $51.53M 1.22%
1.22%
Reduce
26 9.85M $47.95M 1.14%
1.14%
Hold
27 708.95K $46.73M 1.11%
1.11%
Reduce
28 3.36M $45.23M 1.07%
1.07%
Add
29 4.86M $41.96M 1.00%
1.00%
Hold
30 2.43M $39.13M 0.93%
0.93%
Add
31 1.93M $38.40M 0.91%
0.91%
New
32 1.54M $32.93M 0.78%
0.78%
Hold
33 2.89M $31.56M 0.75%
0.75%
Reduce
34 130.00K $29.62M 0.70%
0.70%
New
35 1.40M $28.87M 0.69%
0.69%
Hold
36 207.49K $28.62M 0.68%
0.68%
Reduce
37 2.36M $27.71M 0.66%
0.66%
Add
38 1.79M $27.53M 0.65%
0.65%
Reduce
39 80.00K $27.53M 0.65%
0.65%
Reduce
40 872.97K $27.30M 0.65%
0.65%
Hold
41 718.31K $26.71M 0.64%
0.64%
Reduce
42 2.21M $25.29M 0.60%
0.60%
Hold
43 2.42M $24.02M 0.57%
0.57%
Add
44 97.50K $22.27M 0.53%
0.53%
Add
45 1.10M $22.09M 0.53%
0.53%
Hold
46 1.52M $21.82M 0.52%
0.52%
Reduce
47 641.47K $21.55M 0.51%
0.51%
Hold
48 270.12K $21.52M 0.51%
0.51%
Hold
49 45.00K $20.53M 0.49%
0.49%
Add
50 900.00K $19.15M 0.46%
0.46%
Hold

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q4) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q3)

P 90% R 90% F1 90% (modelled on 2026-Q2; 9/10 hit)

Historical Backtest (7 quarters)

Avg precision 80% · recall 80% · F1 80% · avg rank error 2.1 · Top-10 turnover 24%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2025-Q1 50% 50% 50% SRRK · ONC · KYMR · APLS · CRNX · ARGX · NAMS · BCAX · ARWR · NMRA SRRK · ONC · KYMR · BPMC · CRNX · APLS · IRON · SLNO · ASND · MRUS
2025-Q2 70% 70% 70% SRRK · ONC · KYMR · BPMC · SLNO · CRNX · APLS · IRON · MRUS · NAMS SRRK · KYMR · ONC · IRON · CRNX · BCAX · DYN · CNTA · MRUS · APLS
2025-Q3 90% 90% 90% SRRK · KYMR · ONC · IRON · DYN · BCAX · CRNX · EWTX · CNTA · MRUS SRRK · KYMR · ONC · ARWR · BCAX · CNTA · CRNX · EWTX · IRON · DYN
2025-Q4 80% 80% 80% SRRK · KYMR · ONC · ARWR · BCAX · CNTA · EWTX · CRNX · DYN · IRON SRRK · KYMR · ONC · EWTX · RVMD · CNTA · ARWR · BCAX · OLMA · IRON
2026-Q1 80% 80% 80% SRRK · KYMR · ONC · EWTX · RVMD · CNTA · ARWR · BCAX · OLMA · TNGX SRRK · KYMR · ERAS · EWTX · ONC · TNGX · BCAX · RVMD · ARWR · MANE
2026-Q2 100% 100% 100% SRRK · KYMR · ERAS · EWTX · ONC · TNGX · BCAX · RVMD · ARWR · MANE SRRK · KYMR · ERAS · MANE · TNGX · RVMD · BCAX · ARWR · ONC · EWTX
2026-Q3 ★ 90% 90% 90% SRRK · KYMR · ERAS · MANE · TNGX · BCAX · RVMD · ARWR · RYTM · ONC SRRK · KYMR · ERAS · RVMD · ONC · TNGX · MANE · ARWR · EWTX · RYTM

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

Barra Factor Attribution

The disclosed long US equity book from the 2026-Q3 13F is held at its report-date weights and decomposed over 2026-09-30 ~ 2026-11-11. The model uses 16 Barra style factors plus GICS sector dummies, WLS cross-sectional factor returns and an EWMA factor covariance for risk. The “portfolio” is the visible 13F book, not the fund's true NAV.

13F periodQ3 2026 Attribution quarterQ4 2026 (in progress) Window2026-09-30 → 2026-11-11 Trading days30 Holdings31 Model coverage97.9%

The quarter is not complete yet; the window ends at the latest available price date, 2026-11-11, and will update as prices arrive.

Portfolio return-2.60%Buy & hold
QQQ synthetic benchmark-11.15%Liquidity weighted
Excess return+8.55%vs benchmark
Barra annualised vol40.2%Model estimate
Realised vol42.9%Annualised in window
Weighted beta1.18Raw exposure
Factor / specific risk55% / 45%Share of variance
Top-10 concentration90.3%Of reported value
Portfolio value (start = 100)78.485.091.798.3105.010-0110-2211-11Siren, L.L.C.QQQ syntheticLiquid universe EW
Start = 100. Red = portfolio, dark = QQQ synthetic benchmark, dashed grey = equal-weight model universe.

1. Performance

Metric Value Note
Portfolio return (buy & hold)-2.60%Disclosed long book
QQQ synthetic benchmark-11.15%Liquidity-weighted constituents
Model universe, equal weight+2.07%Opportunity-cost reference
Excess return+8.55%Portfolio − benchmark
Arithmetic return sum-1.58%Difference vs compounded is the cross term
Weighted raw beta1.18Weighted holding betas
Realised volatility (annualised)42.91%Daily returns in window
Barra model volatility (annualised)40.24%Factor + specific
Factor share of variance55.3%Barra factors
Specific share of variance44.7%Stock residuals
Reported value$1.31B13F long US equity

2. Return attribution

The -1.58% arithmetic return splits into style factors, sector factors and specific return; the table is sorted by contribution.

Factor group Factors Contribution Share of |return|
Size & Liquidity 6 -1.26% -79.9%
Momentum & Growth 3 -4.85% -307.9%
Volatility & Tail Risk 7 -0.85% -54.3%
Industry 12 +8.18% 519.1%
Specific 1 -2.79% -177.0%
Return attribution (style + industry, %)-9.0-4.5+0.0+4.5+9.0Information Technology-0.22Turnover-0.41Short-term Reversal+0.61Amihud Illiquidity+0.65Growth-0.97Skewness-1.02Beta+1.67Kurtosis-1.94Size+2.25Mid Cap-3.76Historical Volatility-4.05Residual Volatility+4.36Momentum-4.49Health Care+8.34
Factor Type Exposure Factor return Contribution Share of |return|
Health Care Industry +0.88 +9.47% +8.34% 529.5%
Residual Volatility Style +2.03 +2.15% +4.36% 277.1%
Size Style -1.17 -1.93% +2.25% 142.9%
Beta Style +0.34 +4.92% +1.67% 106.0%
Amihud Illiquidity Style +2.17 +0.30% +0.65% 41.4%
Short-term Reversal Style +0.55 +1.12% +0.61% 38.7%
Leverage (Downside Vol) Style -0.06 -3.05% +0.19% 11.8%
Non-linear Size Style +2.41 +0.07% +0.17% 10.5%
Max Drawdown Style +0.06 -1.01% -0.06% -3.6%
Liquidity Style +0.80 -0.20% -0.16% -10.3%
Information Technology Industry +0.11 -2.11% -0.22% -14.2%
Turnover Style +0.09 -4.35% -0.41% -25.9%
Growth Style -0.65 +1.50% -0.97% -61.8%
Skewness Style +0.21 -4.77% -1.02% -64.8%
Kurtosis Style -0.32 +6.17% -1.94% -123.4%
Specific Specific — — -2.79% -177.0%
Mid Cap Style +1.96 -1.92% -3.76% -238.6%
Historical Volatility Style +0.41 -9.82% -4.05% -257.3%
Momentum Style +1.35 -3.32% -4.49% -284.8%

3. Risk attribution

Annualised volatility is 40.24%; factor risk explains 55.3% of variance and specific risk 44.7%. A negative variance contribution means the factor is negatively correlated with the rest of the book and acts as a partial hedge.

Risk attribution (share of variance, %)-48.2-24.1+0.0+24.1+48.2Growth-1.20Short-term Reversal+0.56Information Technology+1.51Historical Volatility+1.54Non-linear Size+1.94Liquidity+2.31Amihud Illiquidity+2.57Beta+3.84Size+4.34Momentum+6.21Mid Cap+8.55Residual Volatility+9.20Health Care+13.78Specific+44.66
Factor Type Exposure Share of variance Vol contribution Share of vol
Specific Specific — 44.7% +17.97% 18.0%
Health Care Industry +0.88 13.8% +5.55% 5.5%
Residual Volatility Style +2.03 9.2% +3.70% 3.7%
Mid Cap Style +1.96 8.6% +3.44% 3.4%
Momentum Style +1.35 6.2% +2.50% 2.5%
Size Style -1.17 4.3% +1.75% 1.8%
Beta Style +0.34 3.8% +1.55% 1.6%
Amihud Illiquidity Style +2.17 2.6% +1.04% 1.0%
Liquidity Style +0.80 2.3% +0.93% 0.9%
Non-linear Size Style +2.41 1.9% +0.78% 0.8%
Historical Volatility Style +0.41 1.5% +0.62% 0.6%
Information Technology Industry +0.11 1.5% +0.61% 0.6%
Short-term Reversal Style +0.55 0.6% +0.23% 0.2%
Skewness Style +0.21 -0.3% -0.12% -0.1%
Growth Style -0.65 -1.2% -0.48% -0.5%

4. Style exposures

Standardised z-scores; positive means the book leans toward that style versus the model universe, negative means underweight.

Style exposures (z-score)-1.5-0.50.61.72.8Max DrawdownKurtosisSkewnessLeverage (Downside Vol)GrowthTurnoverAmihud IlliquidityLiquidityHistorical VolatilityResidual VolatilityShort-term ReversalMomentumBetaMid CapNon-linear SizeSizePortfolioQQQ benchmark
Style factor Portfolio QQQ benchmark Difference
Size -1.17 +2.10 -3.27
Non-linear Size +2.41 +1.68 +0.73
Mid Cap +1.96 +0.13 +1.83
Beta +0.34 +1.29 -0.95
Momentum +1.35 +0.72 +0.64
Short-term Reversal +0.55 -0.64 +1.19
Residual Volatility +2.03 -0.40 +2.43
Historical Volatility +0.41 +0.86 -0.45
Liquidity +0.80 +0.11 +0.69
Amihud Illiquidity +2.17 +1.16 +1.02
Turnover +0.09 +0.21 -0.11
Growth -0.65 +0.58 -1.23
Leverage (Downside Vol) -0.06 +0.14 -0.20
Skewness +0.21 +0.24 -0.02
Kurtosis -0.32 +0.21 -0.53
Max Drawdown +0.06 -0.08 +0.14

5. Industry allocation & Brinson

Industry allocation (weight, %)-8.817.644.170.596.9Communication ServicesUtilitiesIndustrialsConsumer StaplesConsumer DiscretionaryFinancialsInformation TechnologyHealth CarePortfolioQQQ benchmark
Sector Portfolio Benchmark Portfolio ret Benchmark ret Allocation Selection Interaction Total
Information Technology 10.6% 73.6% -14.94% -16.67% +3.95% +1.27% -1.09% +10.68%
Communication Services 0.0% 2.6% +0.00% -12.15% +0.05% +0.32% -0.32% +0.32%
Utilities 0.0% 0.8% +0.00% +10.14% -0.16% -0.08% +0.08% -0.08%
Consumer Staples 0.0% 0.8% +25.98% +15.33% -0.21% +0.09% -0.09% -0.12%
Financials 0.6% 0.0% -28.83% +0.00% +0.06% -0.00% -0.17% -0.17%
Consumer Discretionary 0.5% 8.8% +7.02% +5.93% -1.36% +0.10% -0.09% -0.49%
Industrials 0.0% 11.1% +0.00% +7.87% -2.03% -0.87% +0.87% -0.87%
Health Care 88.1% 1.7% -1.75% +9.50% +17.19% -0.19% -9.72% -1.71%
Total +17.41% +0.59% -10.48% +7.52%

6. Holdings & contribution

Symbol Name Sector Weight Return Contribution QoQ
SRRK Scholar Rock Holding Corporation Health Care 34.68% -3.56% -1.23% Reduce
RVMD REVOLUTION MEDICINES INC Health Care 13.36% -11.96% -1.60% Reduce
ONC BEONE MEDICINES LTD Health Care 13.03% +14.77% +1.92% Hold
TNGX Tango Therapeutics, Inc. Health Care 12.96% +3.13% +0.40% Add
RLAY Relay Therapeutics, Inc. Health Care 4.51% +9.25% +0.42% Reduce
TSHA Taysha Gene Therapies, Inc. Health Care 3.67% -12.12% -0.45% Hold
DNLI Denali Therapeutics Inc. Health Care 2.21% -4.55% -0.10% Hold
GOOGL ALPHABET INC Information Technology 2.11% -14.71% -0.31% Reduce
GPCR Structure Therapeutics Inc. Health Care 2.09% -33.00% -0.69% Hold
NVDA NVIDIA CORPORATION Information Technology 1.70% -23.93% -0.41% Add
TSM TAIWAN SEMICONDUCTOR MANUFAC Information Technology 1.57% -9.39% -0.15% Add
MSFT MICROSOFT CORP Information Technology 0.94% +1.60% +0.01% Hold
NOW SERVICENOW INC Information Technology 0.92% -23.32% -0.21% Reduce
NBIS NEBIUS GROUP N.V. Information Technology 0.86% -34.42% -0.29% Reduce
GENB Generate Biomedicines Inc Health Care 0.85% -10.19% -0.09% Hold
AVGO BROADCOM INC Information Technology 0.79% -1.70% -0.01% Add
FROG JFrog Ltd. Information Technology 0.49% +12.85% +0.06% Reduce
AMZN AMAZON COM INC Consumer Discretionary 0.41% +6.83% +0.03% Reduce
CRWD CROWDSTRIKE HLDGS INC Information Technology 0.40% -13.48% -0.06% Add
DDOG DATADOG INC Information Technology 0.38% -32.67% -0.12% Reduce
Contribution rank Symbol Sector Weight Return Contribution
1 ONC Health Care 13.03% +14.77% +1.92%
2 RLAY Health Care 4.51% +9.25% +0.42%
3 TNGX Health Care 12.96% +3.13% +0.40%
4 FROG Information Technology 0.49% +12.85% +0.06%
5 AMZN Consumer Discretionary 0.41% +6.83% +0.03%
6 MSFT Information Technology 0.94% +1.60% +0.01%
7 ZTS Health Care 0.07% +18.24% +0.01%
8 PRMB Consumer Staples 0.04% +25.98% +0.01%
9 NVDA Information Technology 1.70% -23.93% -0.41%
10 TSHA Health Care 3.67% -12.12% -0.45%
11 GPCR Health Care 2.09% -33.00% -0.69%
12 SRRK Health Care 34.68% -3.56% -1.23%
13 RVMD Health Care 13.36% -11.96% -1.60%

7. Conclusions

  1. Over the attribution window 2026-09-30 → 2026-11-11 (30 trading days), the reported portfolio returned -2.60%, versus -11.15% for the QQQ synthetic benchmark — an excess of +8.55%.
  2. Return attribution: the largest positive style/industry contributions came from Health Care +8.34%, Residual Volatility +4.36%, Size +2.25%; the largest drags came from Momentum -4.49%, Historical Volatility -4.05%, Mid Cap -3.76%. Specific (stock-level) return contributed -2.79%.
  3. Risk attribution: Barra model volatility is 40.24% annualised; factor risk explains 55% of variance and specific risk 45%. The largest factor risk sources are Health Care 13.8%, Residual Volatility 9.2%, Mid Cap 8.6%.
  4. Style tilt: size -1.17, momentum +1.35, volatility +0.41, liquidity +0.80; the weighted raw beta is 1.18. Positive z-scores mean the portfolio leans toward that style versus the cross-section.
  5. Industry: the largest overweight versus the benchmark is Health Care (+86.4 pp), the largest underweight is Information Technology (-63.0 pp). Allocation contributed +17.41%, selection +0.59% and interaction -10.48%.
  6. Concentration: the top-10 positions are 90.3% of the attributed portfolio and the model covers 97.9% of its value with full style exposures; the remainder is mapped to its sector only. This is a high-conviction, long-only 13F book — not the fund's complete NAV.
Methodology & caveats
  • 13F discloses long US equity (including some options) only; cash, shorts and non-US positions are absent. This is not the fund's true NAV.
  • Weights are the report-date reported values and stay fixed over the window (buy & hold); intra-quarter trading and flows are not captured.
  • Factor exposures are measured at quarter end and held through the next quarter; style factors are cross-sectionally orthogonalised and read as incremental exposures.
  • The database has no share-count data, so size and liquidity use dollar volume (price × volume) as a proxy; Size is closer to “traded-value scale”.
  • Factor returns come from a WLS cross-sectional regression on the model universe; risk is annualised, and some factor variance contributions can be negative.
  • 13F filings lag by up to 45 days, so the stretch from the report date to the filing date was not actionable in real time.
  • Sector mapping uses one consistent GICS level-1 scheme for both the portfolio and the benchmark.

FAQ

What did Siren, L.L.C. buy in 2026-Q3?

In its 2026-Q3 13F filing, Siren, L.L.C. reported 109 equity positions worth $4.21B in aggregate; its largest disclosed positions were SRRK ($453.00M), KYMR ($311.32M), ERAS ($193.48M).

How large is Siren, L.L.C.'s portfolio?

Siren, L.L.C. reported $4.21B of long equity holdings across 109 positions as of 2026-Q3. Top-10 holdings account for 47.5% of reported value.

What is Siren, L.L.C.'s investment style?

HoldingsHub classifies the portfolio as Mid / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/siren/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →